Managing Comorbidities with COPD

Activity Details
  • Credit Amounts:
    • CPE: 1.00
    • CNE: 1.20
    • Physicians: 1.00
  • Cost: Free
  • Release: Feb 23, 2016
  • Expires: Feb 23, 2018
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Carlos H.  Martinez Carlos H. Martinez, MD, MPH
Assistant Professor, Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan

Needs Statement

For the patient with COPD, it is seldom the only illness diagnosed. The existence of co-morbid conditions and the severity of COPD symptoms greatly the impact the mortality and quality of life for the COPD patient.  This presentation describes the frequency and impact of comorbidities and the management of COPD.

Target Audience

This program was designed to address the educational needs of physicians, phyisican assistant, nurses, nurse practitioners and pharmacists.

Objectives

• Identify the impact comorbidities have on management of COPD  
• Identify strategies for management of COPD with multiple comorbidities  
• Explore the strengths and weaknesses of comorbidity research

Accreditation

CPE
ACPEThe University of North Texas Health Science Center is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 0845-0000-15-104-H04-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. UNTHSC complies with the Accreditation Standards for Continuing Pharmacy Education.

CNE

UNT Health Science Center is approved by the California Board of Registered Nursing, Provider # 16274. This activity is approved for 1.20 Contact Hours.

Physicians

The University of North Texas Health Science Center is accredited by the American Osteopathic Association to award continuing medical education to physicians.

The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 1.00 hour of AOA Category 2B CME credits. Approval is currently pending.

The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of North Texas Health Science Center designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of North Texas Health Science Center presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Patient care
  • Practice-based learning and improvement

IOM Competencies

  • Provide patient-centered care
  • Employ evidence-based practice

Faculty Disclosure

Dr. Martinez has nothing to disclose.

The UNT Health Science Center Professional and Continuing Education Staff and Grand Rounds Planning Committee have nothing to disclose.

OFF-LABEL Use:

Dr. Martinez will discuss macrolide use for COPD exacerbation prevention and the association between beta-blockers and COPD exacerbations.

Acknowledgement

Supported by an unrestricted educational grant from Boehringer Ingelheim.

The activity was supported by PACE - General.